Egg freezing today is not an insurance policy that can guarantee a baby in the future. Clinics have a responsibility to ensure anyone using fertility services understand the optimum age for freezing, the success rates as well as the risks.”
CHLOE OQ™ is predictive of an egg’s chance to form a blastocyst4,*
CHLOE OQ™ allows you to:
Assess eggs within
the safety of the
Capture images automatically saving you time
Mitigate human mix-up errors with secure
Enable personalized family planning for your patients
Adding CHLOE OQ to your workflow:
Dr Cristina Hickman,
Chief Clinical Officer
Dr Laura Rienzi,
Director of the Scientific Executive Committee of GeneraLife, Associate Professor @University of Urbino “Carlo Bo”, Italy
Fairtility unveils CHLOE OQ™ expanding its offering into fertility preservation – FemTech World
CHLOE OQ brings the power of AI to oocyte assessment, replacing generalized decision-making with personalised, data-driven AI analysis that reveals the potential of each oocyte backed by biological data.
Fairtility Launches CHLOE OQ, A New AI-Powered Fertility Preservation Offer (femtechinsider.com)
CHLOE OQ, which has also received CE certification, now brings AI-powered assessment to oocyte evaluation, replacing subjective decision-making with personalized, data-driven analysis. It stands to enhance decision-making across three key areas: egg freezing, egg donation, and IVF treatment.
New AI Fertility Tool Optimizes Reproductive Potential (nocamels.com)
Oocyte potential prediction for reaching blastulation and pregnancy commonly relies on statistical methods based on a woman’s age. Embryologists analyze oocyte quality based on oocyte maturity and characteristics including size, texture, shape, discoloration and fragmentation. These factors have proven to be subjective and lack correlation with the actual quality of the egg, according to ESHRE.